航天彩虹(002389.SZ):就掛牌轉讓電容膜業務相關資產 最終確定浙江華誠為受讓方並簽署相關交易合同
格隆匯11月24日丨航天彩虹(002389.SZ)公佈,此前披露,公司於2021年9月23日召開2021年第二次臨時股東大會審議通過了《關於擬整合剝離電容膜業務的議案》,同意公司通過產權交易所以公開掛牌形式整體處置公司電容膜業務,轉讓價格不低於評估報吿確定的評估值。
根據上述股東大會通過的電容膜業務剝離方案,此次掛牌擬轉讓的資產包括:浙江南洋科技有限公司聚丙烯電容器薄膜業務板塊淨資產、台州富洋投資有限公司100%股權、鶴山市廣大電子有限公司100%股權,根據北京產權交易所的反饋結果,最終確定浙江南洋華誠科技有限公司(“浙江華誠”)為受讓方,成交價格合計31791.61萬元。交易雙方已就此次交易簽署了相關交易合同。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.